Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants

This study has been terminated.
(difficulty in recruiting subjects)
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
University of Louisville
ClinicalTrials.gov Identifier:
NCT00265005
First received: December 12, 2005
Last updated: March 8, 2016
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2012
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)